REQUEST A DEMO
Total
USD $0.00
Search more companies

Bioholistic S.A.S Centro Colombiano De Medicina Integral (Colombia)

Main Activities: Ambulatory Health Care Services
Full name: Bioholistic S.A.S Centro Colombiano De Medicina Integral Profile Updated: October 02, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Bioholistic S.A.S Centro Colombiano De Medicina Integral is a company in Colombia, with a head office in Santa Marta. The enterprise currently operates in the Ambulatory Health Care Services sector. The company was established on February 18, 2016. From the latest financial highlights, Bioholistic S.A.S Centro Colombiano De Medicina Integral reported a net sales revenue increase of 169.23% in 2024. Its’ total assets recorded a growth of 140.01%. The net profit margin of Bioholistic S.A.S Centro Colombiano De Medicina Integral increased by 0.71% in 2024.

Headquarters
Cl 18 11 50
Santa Marta; Magdalena;

Contact Details: Purchase the Bioholistic S.A.S Centro Colombiano De Medicina Integral report to view the information.

Basic Information
Registered Capital:
Purchase the Bioholistic S.A.S Centro Colombiano De Medicina Integral report to view the information.
Financial Auditors:
Purchase the Bioholistic S.A.S Centro Colombiano De Medicina Integral report to view the information.
Incorporation Date:
February 18, 2016
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Bioholistic S.A.S Centro Colombiano De Medicina Integral report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
169.23%
Total operating revenue
169.23%
Operating profit (EBIT)
252.28%
EBITDA
252.28%
Net Profit (Loss) for the Period
262.06%
Total Assets
140.01%
Total Equity
15.45%
Operating Profit Margin (ROS)
1.03%
Net Profit Margin
0.71%
Return on Equity (ROE)
9.12%
Quick Ratio
-1.24%
Cash Ratio
-1.32%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?